Prothena | PRTA - Trade Debtors


Prothena reported $5.16M in Trade Debtors for its fiscal quarter ending in December of 2023.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
ALKERMES USD 407.63M 73.6M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Exelixis USD 328.95M 42.03M Mar/2026
Immunic USD 333K 156K Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
MacroGenics USD 13.37M 55.86M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Xoma USD 14.78M 4.96M Jun/2024